[Clostridum difficile associated disease in Latin America].

Authors:
Address: Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México D.F., México.
Journal:


Publication:

abstract

Clostridium difficile associated disease (CDAD) has shown a sustained increase worldwide over the last ten years. However, there are few studies on this topic in Latin America. We conducted a comprehensive literature review using medical databases of Latin American countries. We found only seven recent papers in which clinical characteristics and risk factors were analyzed; some included outcome variables. Of these articles, only one was prospective, while the rest were either retrospective, cross-sectional or case-control studies. Most studies were done among hospitalized adult patients, even though patients 13+ years were also included in some reports. Only two recent clinical studies used cell culture to determine a cytopathic effect and the rest included immunoenzymatic assays. In general, all the studies we reviewed showed that the use of fluorquinolones, clindamycin, and cephalosporins were the antibiotics mostly associated with CDAD. Treatment schedules generally included metronidazol, although vancomycin was reported in one. Attributable mortality was lower than the mortality described in previous reports from hospitals in developed countries. Studies where this outcome was included did not surpass 4%, a significant difference from the findings from developed countries. In Latin America there are few studies that describe this clinical problem, they generally include small sample sizes and most are retrospective. There is a clear need to design and carry out prospective studies that will allow us to determine the true prevalence of this health problem



Related Articles
Review A literature review of the epidemiology of sepsis in Latin America.
Rev Panam Salud Publica. 2005
Review A literature review of the epidemiology of sepsis in Latin America.
Jaimes F. Rev Panam Salud Publica. 2005 Sep; 18(3):163-71.
[Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD)].
Korean J Gastroenterol. 2009
[Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD)].
Byun TJ, Han DS, Ahn SB, Cho HS, Kim TY, Eun CS, Jeon YC, Sohn JH, Kang JO. Korean J Gastroenterol. 2009 Jul; 54(1):13-9.
Case-controlled review of Clostridium difficile-associated diarrhoea in southern Tasmania.
J Clin Pharm Ther. 1997
Case-controlled review of Clostridium difficile-associated diarrhoea in southern Tasmania.
Halim HA, Peterson GM, Friesen WT, Ott AK. J Clin Pharm Ther. 1997 Oct-Dec; 22(5-6):391-7.
Review Established and potential risk factors for Clostridum difficile infection.
Indian J Med Microbiol. 2009
Review Established and potential risk factors for Clostridum difficile infection.
Vaishnavi C. Indian J Med Microbiol. 2009 Oct-Dec; 27(4):289-300.
Relation between the global burden of disease and randomized clinical trials conducted in Latin America published in the five leading medical journals.
PLoS One. 2008
Relation between the global burden of disease and randomized clinical trials conducted in Latin America published in the five leading medical journals.
Perel P, Miranda JJ, Ortiz Z, Casas JP. PLoS One. 2008 Feb 27; 3(2):e1696. Epub 2008 Feb 27.
Review The changing epidemiology of Clostridium difficile infections.
Clin Microbiol Rev. 2010
Review The changing epidemiology of Clostridium difficile infections.
Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH. Clin Microbiol Rev. 2010 Jul; 23(3):529-49.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.